ENT Private Equity: What Selling Your Practice Means
ENT private equity activity has made selling an otolaryngology practice look very different than it did a generation ago. Private equity groups have shown interest in ENT because the specialty is fragmented, procedure-oriented and rich in ancillary services such as audiology, allergy, imaging and sleep testing. Many independent otolaryngologists now receive outreach from investors or their representatives, often with little context about what a sale would actually involve.
This article explains how private equity transactions in otolaryngology generally work, what changes after closing and how a sale compares with keeping the practice independent. Deal terms vary widely, and nothing here is legal, tax, investment, billing or compliance advice. Sellers should work with experienced healthcare counsel, accountants and advisors.
Why Investors Look at Otolaryngology
Investors often view ENT as a specialty where a larger organization can add value by centralizing services. Common themes include:
- A large number of small and mid-sized independent practices
- Ancillary services that can be expanded across multiple locations
- Opportunities to centralize billing, purchasing, staffing and technology
- Surgical volume that may connect to surgery center ownership
A larger platform practice is often acquired first, then smaller practices are added over time. Platform and add-on practices may be valued and structured differently.
How an ENT Private Equity Deal Is Typically Structured
Every transaction is different, but many share similar components. Physicians typically receive a portion of the purchase price in cash at closing. Another portion may be paid as equity in the new parent organization, often called rollover equity, which may gain or lose value depending on how the platform performs and when it is sold again.
Physicians usually sign new employment agreements with defined compensation, which is often lower than what they earned as owners because some earnings are now paid to the investor. Some deals also include earnouts or deferred payments tied to future performance. These terms can create friction after closing if targets or cost allocations are disputed, so they should be reviewed carefully with counsel.
Because many medical practices must be owned by licensed physicians under state law, these transactions often use management services arrangements. How those arrangements work varies by state and should be explained by healthcare counsel.
What Changes After the Sale
Selling to private equity can change daily life in the practice. Physicians may notice:
- Centralized decisions on staffing, purchasing, technology and payer contracting
- Shared management costs allocated across practices
- New policies on scheduling, productivity and ancillary use
- Restrictive covenants that limit future practice options, which should be reviewed by counsel
Some physicians welcome the reduced administrative burden. Others find that the loss of control matters more than they expected.
Valuation in a Private Equity Sale
Investors typically focus on normalized earnings after the new physician compensation is set. That means a higher offer price can come with a lasting reduction in physician income. Sellers should compare the full picture: cash at closing, rollover equity, compensation over the employment term and restrictions after the term ends. Our guide to ENT practice valuation explains the factors that drive value in the specialty.
Diligence Issues That Can Derail a Deal
Private equity buyers conduct extensive diligence. Ancillary services receive particular attention, since referral, ownership and billing arrangements in imaging, audiology, allergy and other services are subject to federal and state rules. Issues found in diligence can lower the price, change the structure or end the transaction. Owners can learn more in our article on ENT ancillary services, and should have counsel and qualified compliance professionals review arrangements before going to market.
Alternatives to a Private Equity Sale
Private equity is one option, not the only one. Many otolaryngologists prefer to keep the practice independent and transfer ownership internally.
- Selling to associates or junior partners: often financed with practice acquisition loans, keeping ownership with physicians who know the patients
- Partner buyouts: remaining owners purchase a retiring partner’s interest. See our guide on the ENT partner buyout.
- Selling to an outside physician: an individual buyer financing the purchase with a lender
- Hospital or health system employment: another form of sale with its own terms
An internal sale may result in a different price, but it can preserve independence, culture and the physicians’ long-term control. Lender financing can help internal buyers compete with institutional offers, subject to approval.
Questions to Ask Before Signing a Letter of Intent
- How much of the price is cash at closing versus rollover equity or deferred payments?
- What will physician compensation look like, and how is it calculated?
- How are management fees and shared costs allocated?
- What restrictive covenants apply, and for how long?
- How will younger physicians who join later be treated?
- What happens to surgery center interests and ancillary services?
Planning Ahead
Whether a private equity sale is right depends on the owner’s goals, age, partners and appetite for continued work. Starting early gives time to clean up financials, review ancillary arrangements and develop internal successors as a realistic alternative. Our guide to ENT practice succession walks through that planning process.
Final Thoughts
ENT private equity offers can be attractive, but they involve trade-offs in compensation, control and long-term flexibility. Comparing those offers with an internal sale or partner buyout, with help from experienced advisors, can help owners choose the path that best fits their goals.
US Medical Funding helps otolaryngologists finance internal sales, partner buyouts and acquisitions that keep practices independent. Learn more about our advisory and succession services and our full range of otolaryngology practice financing options.
